Table 1.
Epidemiology | Incidence of 14 cases/1,000 person-years* |
Clinical presentation and evaluation | Tachypnea, dyspnea, bronchospasm |
Failure to thrive, malaise, delirium | |
Fever, cough, purulent sputum | |
+/− infiltrate on chest x-ray | |
Leukocytosis | |
Risk factors | Age |
Influenza infection | |
Comorbid conditions | |
Treatment | Antibiotics according to IDSA/ATS guidelines |
Determinants of outcome and health-related quality of life | Severity of acute infection\ |
Comorbidities | |
Functional status prior to disease | |
Possible link between male gender and mortality |
Notes: ATS = American Thoracic Society ; IDSA = Infectious Diseases Society of America.
Incidence doubled in nursing home residents.